Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that
protect against severe disease and preferably drive herd immunity. Regulators in numerous …
protect against severe disease and preferably drive herd immunity. Regulators in numerous …
Cost-effectiveness and economic benefits of vaccines in low-and middle-income countries: a systematic review
S Ozawa, A Mirelman, ML Stack, DG Walker… - Vaccine, 2012 - Elsevier
BACKGROUND: Public health interventions that prevent mortality and morbidity have greatly
increased over the past decade. Immunization is one of these preventive interventions, with …
increased over the past decade. Immunization is one of these preventive interventions, with …
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to
reach more than five million people in developing countries. Essential to this achievement …
reach more than five million people in developing countries. Essential to this achievement …
How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis: Article describes and analyzes how resources …
Coronavirus disease 2019 (COVID-19) vaccine development and manufacturing have
proceeded at a historically unprecedented pace. This speed may be accounted for by the …
proceeded at a historically unprecedented pace. This speed may be accounted for by the …
The economics of agricultural innovation
Throughout history and in every part of the world, innovation in agriculture has played
crucial roles in economic development by increasing farm productivity, enhancing the …
crucial roles in economic development by increasing farm productivity, enhancing the …
Innovation inducement prizes: Connecting research to policy
H Williams - Journal of Policy Analysis and Management, 2012 - Wiley Online Library
Innovation inducement prizes have been used for centuries. In the U nited S tates, a recent
federal policy change—the A merica COMPETES R eauthorization A ct of 2010—clarified …
federal policy change—the A merica COMPETES R eauthorization A ct of 2010—clarified …
Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a …
MG Lucero, H Nohynek, G Williams… - The Pediatric …, 2009 - journals.lww.com
Background: Pneumococcus is a leading cause of childhood pneumonia worldwide.
Pneumococcal conjugate vaccines (PCV) have demonstrated efficacy against childhood …
Pneumococcal conjugate vaccines (PCV) have demonstrated efficacy against childhood …
HIV prevention cost-effectiveness: a systematic review
Background After more than 25 years, public health programs have not been able to
sufficiently reduce the number of new HIV infections. Over 7,000 people become infected …
sufficiently reduce the number of new HIV infections. Over 7,000 people become infected …
[图书][B] Policies and incentives for promoting innovation in antibiotic research
E Mossialos, CM Morel, S Edwards, J Berenson… - 2010 - apps.who.int
High levels of pathogen resistance are rendering current antibiotics obsolete. Coupled with
insufficient investment in discovering new treatments, multidrug-resistant infections are an …
insufficient investment in discovering new treatments, multidrug-resistant infections are an …
Market failure and the poverty of new drugs in maternal health
Market Failure and the Poverty of New Drugs in Maternal Health | PLOS Medicine Skip to main
content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues …
content Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues …